Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics

Bladder cancer is a frequent malignancy and has a clinical need for new therapeutic approaches. Antibody and protein technologies came a long way in recent years and new engineering approaches were applied to generate innovative therapeutic entities with novel mechanisms of action. Furthermore, mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogen, Jan P., Grzeschik, Julius, Jakobsen, Joern, Bähre, Alexandra, Hock, Björn, Kolmar, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191463/
https://www.ncbi.nlm.nih.gov/pubmed/34123841
http://dx.doi.org/10.3389/fonc.2021.672262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191463/
https://www.ncbi.nlm.nih.gov/pubmed/34123841
http://dx.doi.org/10.3389/fonc.2021.672262

Ejemplares similares